References

• Hoffmann, J. P., Liu, J. A., Seddu, K., & Klein, S. L. (2023). Sex hormone signaling and regulation of immune function. Immunity, 56(11), 2472–2491. https://doi.org/10.1016/j.immuni.2023.10.008
• Kim, Y. J., Soto, M., Branigan, G. L., Rodgers, K., & Brinton, R. D. (2021). Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 7(1), Article e12174. https://doi.org/10.1002/trc2.12174
• Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., Fox, N. C., Ferri, C. P., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Nakasujja, N., Rockwood, K., … Mukadam, N. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. The Lancet, 404(10452), 572–628. https://doi.org/10.1016/S0140-6736(24)01296-0
• Matthews, K. A., Kuller, L. H., Sutton-Tyrrell, K., & Chang, Y.-F. (2001). Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke, 32(5), 1104–1111. https://doi.org/10.1161/01.STR.32.5.1104
• McCarthy, M., & Raval, A. P. (2020). The perimenopause in a woman’s life: A systemic inflammatory phase that enables later neurodegenerative disease. Journal of Neuroinflammation, 17(1), Article 317. https://doi.org/10.1186/s12974-020-01998-9
• Mosconi, L. (2024). The menopause brain: New science empowers women to navigate menopause with knowledge and confidence. Avery.
• Mosconi, L., Nerattini, M., Matthews, D. C., Jett, S., Andy, C., Williams, S., Yepez, C. B., Zarate, C., Carlton, C., Fauci, F., Ajila, T., Pahlajani, S., Andrews, R., Pupi, A., Ballon, D., Kelly, J., Osborne, J. R., Nehmeh, S., Fink, M., … Brinton, R. D. (2024). In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology. Scientific Reports, 14(1), Article 12680. https://doi.org/10.1038/s41598-024-62820-7
• Paschou, S. A., Athanasiadou, K. I., & Papanas, N. (2024). Menopausal hormone therapy in women with type 2 diabetes mellitus: An updated review. Diabetes Therapy, 15(4), 741–748. https://doi.org/10.1007/s13300-024-01546-1
• Pe’er, E. (2021). Progestogens and the menopause. In H. J. A. Carp (Ed.), Progestogens in obstetrics and gynecology (pp. 193–202). Springer. https://doi.org/10.1007/978-3-030-52508-8_12
• Cerdas Pérez, S. (2023). Menopause and diabetes. Climacteric, 26(3), 216–221. https://doi.org/10.1080/13697137.2023.2184252